The mean score changes of the St. George’s Respiratory Questionnaire (version 2.2) at W24 vs. baseline data (FAS and PP populations).

Figshare2021-12-23 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/The_mean_score_changes_of_the_St_George_s_Respiratory_Questionnaire_version_2_2_at_W24_vs_baseline_data_FAS_and_PP_populations_/17431596 数据链接链接失效反馈

官方服务：

资源简介：

The mean score changes of the St. George’s Respiratory Questionnaire (version 2.2) at W24 vs. baseline data (FAS and PP populations).

创建时间：

2021-12-23

Dataset from A Randomized, Double-Blind, Multi-Center, Parallel-Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD (Ethos)

COPD药物临床试验

呼吸系统疾病疗效评估

This is a randomized, double-blind, multi-center, parallel-group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations subjects with moderate to very sev

NIAID Data Ecosystem40

Dataset from A Randomized, Double Blind, (Test Products), Chronic Dosing (7 Days), Four Period, Eight Treatment , Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Five Doses of PT003, One Dose of PT001 and One Dose of PT005 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open Label) as Active Control

COPD药物临床试验

呼吸系统疾病疗效评估

The primary objective of this study is to assess the efficacy of Glycopyrrolate/Formoterol Fumarate MDI relative to individual components (GP MDI and FF MDI) in subjects with moderate to severe COPD

NIAID Data Ecosystem30

A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma

哮喘药物临床试验

呼吸系统疾病疗效评估

The purpose of this study is to determine whether Benralizumab reduces the number of asthma exacerbations in patients who remain uncontrolled on high doses of ICS-LABA.

DataCite Commons2025-05-01 更新20

Dataset from A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) (COURSE)

COPD药物临床试验

呼吸系统疾病疗效评估

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive

NIAID Data Ecosystem30

Supplementary Material for: Efficacy of the Spiration Valve System in Patients with Severe Heterogeneous Emphysema: A Systematic Review and Meta-Analysis

肺气肿介入治疗

呼吸系统疾病疗效评估

Background: Spiration Valve System (SVS) is an alternative for patients with severe heterogeneous emphysema; however, data about efficacy from randomized controlled trials (RCT) are unclear. Objective

Figshare2019-11-22 更新30

The mean score changes of the St. George’s Respiratory Questionnaire (version 2.2) at W24 vs. baseline data (FAS and PP populations).

资源简介：

相关数据集